PXS-5338

N/A

Report date: 2026/01/16 15:10:05

NME

Base Information

Drug NamePXS-5338

Drug Alias NamePXS-5338PXS-5338K

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLysyl oxidase homolog 2 inhibitors

TargetsLysyl oxidase homolog 2

Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSyntara Ltd

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSyntara Ltd

Active IndicationsN/A

Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

ATC CodeN/A